Pharmaceutical Executive
Company faces two Vioxx setbacks in court as it prepares to reveal safety data on its cox-2 successor.
Pharmaceutical Executive-08-30-2006
Pharmaceutical Executive
Recent analysis shows partial or complete invalidation of all pharma patents challenged since December 2004.
Pharmaceutical Executive
Schering-Plough's successful allergy medication gets an updated ad campaign.
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
